logo
Plus   Neg
Share
Email

ANI Pharma Acquires U.S. Portfolio Of 23 Generic Products From Amerigen

ANI Pharmaceuticals Inc. (ANIP) said that it has acquired the U.S. portfolio of 23 generic products from Amerigen Pharmaceuticals Ltd. for $52.5 million in cash at close and up to $25 million in contingent profit share payments over the next four years.

The acquired portfolio includes ten commercial products, three approved products with launches pending, four filed products and four in-development products as well as a license to commercialize two approved products.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Off-price retailer Tuesday Morning Corp. (TUES) on Wednesday filed voluntary petitions for protection under Chapter 11 of the Bankruptcy Code in the U. S. Bankruptcy Court for the Northern District of Texas, Dallas Division. It plans to emerge as a stronger company by early fall 2020. The company... Switzerland has launched coronavirus contact-tracing app that was developed using the Exposure Notifications technology from Google and Apple, to prevent further spread of the virus. SwissCovid App, jointly developed by teams at ETH Zurich and EPF Lausanne on behalf of the federal government, is the first app to use the latest application programming interface or API from the U.S. tech majors. Latam Airlines Group SA, one of the largest air carrier in South America, has filed for bankruptcy protection in New York amid the ongoing Covid-19 pandemic, which has grounded flights worldwide. This Chapter 11 filing allows Latam to work with its creditors and other stakeholders to reduce its debt,...
Follow RTT